Samsca Tablet
Product Images NDC 59148-021

This is a description of Samsca medication. Samsca tablets contain 15 mg of haptan. It is recommended to store it at 25°C (77°F) and excursions between 15°C -30°C (59°F - 86°F) are permitted. The medication is distributed and marketed by Otsuka America Pharmaceutical, Inc., Foskuil, D 20250. Samsca medication is produced by Otsuka Pharmaceutical Co., Ltd, Togo, 1018535 Japan. It comes in a package of 10 tablets, and each package contains 1 strip with 10 tablets. It is a prescription-only medication, and patients should be given a medication guide along with its distribution.*

This description provides medication information for Samsca (tolvaptan). This medication comes in a package containing 10 tablets, each containing 30 mg of vaptan. The NDC (National Drug Code) for this package is 59148-021-50. The package includes a dosage information leaflet and storage instructions. The medication should be stored at 25°C (77°F), with excursions permitted between 15°C -30°C (59°F - 86°F). Samsca medication is distributed and marketed by Otsuka America Pharmaceutical, Inc. in Rockville, MD. It is important to note that Samsca is a prescription drug and should only be initiated in a hospital setting. Each patient should receive the enclosed medication guide when receiving this medication.*

This is a clinical study comparing Tolvaptan (at a dosage of 1560 mg) with Placebo in treating a certain condition. The study was conducted with a sample size of 110 people for Tolvaptan and 105 people for Placebo. The study analyzed Mean Serum Sodium levels at different time points: Baseline, 8h, 24h, and 7-Day Follow-Up. The statistical analysis showed a significant improvement with Tolvaptan over Placebo (p<0.0001).*

This appears to be a chart or graph displaying mean serum sodium levels and the effect of Tolvaptan (a medication used to treat low levels of sodium in the blood) on those levels over a period of time. The chart shows a significant improvement in serum sodium levels with Tolvaptan compared to the baseline. There is also mention of a washout week, which may indicate a period of time where the medication was not given to the participants to see if there was any lasting effect on their sodium levels.*